Home LiteratureArticle Details
PMID: 5822582 Published · ppublish English Journal Article

Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study.

The Journal of clinical investigation ·Vol. 48 ·No. 9 ·1969-09-00 ·Pages 1740-53

Bernik MB, Kwaan HC

Abstract

Human tissues and cells from pre- and postnatal life were cultivated and studied for plasminogen activator activity. Cultures were obtained from kidney, renal blood vessels, ureter, bladder, lung, and heart. Local activator activity of cells was demonstrated by histochemical techniques. Activator released by cells into the supernatant culture media was assayed by fibrin plate techniques and was investigated for immunological identity using specific antisera to an activator of human origin, urokinase (UK). Plasminogen activator was produced in primary cultures where cells retain specific functions and generally reflect the enzyme pattern of the tissues of origin. Cells from fetal and adult sources were found to yield activator antigenically identical to UK, as well as activator activity which differed from that of UK in immunoassays and which may represent tissue type activator. Such activity was released after injury or death of cells while UK was produced in cultures containing live, metabolizing cells. Primary cultures of kidney confirmed that this organ is a rich source of UK and demonstrated, in addition, that UK is produced from the early stages of gestation and in increasing amounts thereafter. However, primary cultures also demonstrated that the ability to produce UK is not limited to the kidney but is a function of cells which are distributed widely in body tissues. Thus, activator antigenically identical to UK accumulated progressively after many refeedings in culture supernates of fetal lung and ureter, as well as in supernates of renal blood vessels of adults. These findings indicate continuous formation of UK by the cultured cells and, furthermore, provide evidence of UK production in blood vessels. In cultures from other tissues, particularly those from fetal heart and adult lung and bladder, investigation of activator was hindered by inhibitory activity which accumulated in the supernates. Such activity was derived from cells in culture and was directed selectively against UK, indicating that inhibitor as well as UK are produced by cells of various organs of the body. Plasminogen activator also was produced by serially propagated cells, diploid and heteroploid. However, only diploid cell lines retained activator activity of the original tissues and continued to produce activator antigenically identical to UK. In contrast, heteroploid line appeared to have lost the ability to form UK by yielded activator activity that differed from that of UK in immunoassays. Serially propagated cells thus provide an additional tool for in vitro study of plasminogen activator and may facilitate investigation of the fibrinolytic system in man.

MeSH Terms
Animals Culture Techniques Fetus/analysis Histocytochemistry Humans Kidney/analysis Lung/analysis Methods Myocardium/analysis Neutralization Tests Plasminogen/analysis Renal Artery/analysis Renal Veins/analysis Ureter/analysis Urinary Bladder/analysis
Chemicals
Plasminogen
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bernik M B
Kwaan H C
References (29)
29 references, click to expand
  1. On the production of plasma fibrinolytic activity within veins.
    Clin Sci. 1957 May;16(2):241-53 PMID: 13427182
  2. Characterization of a soluble plasminogen activator from kidney cell cultures.
    Am J Physiol. 1962 Jun;202:1125-30 PMID: 14483249
  3. Nutrition needs of mammalian cells in tissue culture.
    Science. 1955 Sep 16;122(3168):501-14 PMID: 13255879
  4. Urokinase inhibitor in human placenta.
    Nature. 1968 Jan 20;217(5125):253-4 PMID: 5639129
  5. Activation of plasminogen.
    Ann N Y Acad Sci. 1957 Aug 30;68(1):38-51 PMID: 13479018
  6. The preparation of human fibrinolysin (plasmin).
    Vox Sang. 1960 Jul;5:357-76 PMID: 13750527
  7. Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.
    Biochemistry. 1969 Jan;8(1):79-86 PMID: 5777345
  8. Release of plasminogen activator by the isolated perfused dog kidney.
    Nature. 1965 Oct 16;208(5007):291-2 PMID: 4222762
  9. The isolation and characterization of plasminogen activators (urokinase) from human urine.
    Biochemistry. 1966 Jul;5(7):2160-9 PMID: 4959959
  10. The fibrin plate method for estimating fibrinolytic activity.
    Arch Biochem Biophys. 1952 Oct;40(2):346-51 PMID: 12997222
  11. BOVINE FIBRINOGEN WITHOUT DETECTABLE PLASMINOGEN.
    Anal Biochem. 1965 Apr;11:149-52 PMID: 14328637
  12. Antiplasmins.
    Fed Proc. 1966 Jan-Feb;25(1):63-7 PMID: 4143744
  13. STUDIES ON HYALINE MEMBRANE DISEASE. II. THE ONTOGENY OF THE FIBRINOLYSIN SYSTEM.
    Pediatrics. 1965 Jan;35:91-6 PMID: 14223231
  14. An activator of plasminogen produced by cell culture.
    Proc Soc Exp Biol Med. 1959 Nov;102:308-11 PMID: 13796910
  15. Heat denaturation of plasminogen in the fibrin plate method.
    Acta Physiol Scand. 1953 Feb 28;27(4):371-6 PMID: 13065142
  16. The estimation of fibrinolytic components by means of the lysis time method.
    Scand J Clin Lab Invest. 1958;10(4):384-9 PMID: 13615243
  17. Origin of fibrinolytic activity in cultures of the human kidney.
    J Lab Clin Med. 1967 Oct;70(4):650-61 PMID: 6052965
  18. Observations on the inactivation of fibrinolytic activity in shed blood.
    Clin Sci (Lond). 1952 Aug;11(3):309-14 PMID: 12979213
  19. Amino acid metabolism in mammalian cell cultures.
    Science. 1959 Aug 21;130(3373):432-7 PMID: 13675766
  20. The serial cultivation of human diploid cell strains.
    Exp Cell Res. 1961 Dec;25:585-621 PMID: 13905658
  21. ENHANCEMENT OF FIBRINOLYSIS IN THE DOG BY INJECTION OF VASOACTIVE DRUGS.
    Am J Physiol. 1965 Mar;208:511-20 PMID: 14264743
  22. Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action.
    J Exp Med. 1952 Jun;95(6):593-603 PMID: 14946322
  23. The biochemistry and physiology of urokinase.
    Am J Cardiol. 1960 Aug;6:409-19 PMID: 13808740
  24. Demonstration of cellular fibrinolytic activity by the histochemical fibrin slide technique.
    Lab Invest. 1967 Aug;17(2):140-5 PMID: 6053020
  25. SELECTIVE INHIBITION IN HUMAN PREGNANCY BLOOD OF UROKINASE INDUCED FIBRINOLYSIS.
    Scand J Clin Lab Invest. 1963;15:603-9 PMID: 14077014
  26. Tissue activators of plasminogen.
    Fed Proc. 1966 Jan-Feb;25(1):42-51 PMID: 5006793
  27. Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase.
    J Clin Invest. 1968 Jun;47(6):1238-53 PMID: 5653207
  28. PARTIAL PURIFICATION AND PROPERTIES OF THE PLASMINOGEN ACTIVATOR FROM PIG HEART.
    Biochemistry. 1964 Oct;3:1578-85 PMID: 14230807
  29. A cellophane-strip technique for culturing tissue in multipurpose culture chambers.
    J Biophys Biochem Cytol. 1958 Nov 25;4(6):761-4 PMID: 13610941
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1969-09-00
Pages
1740-53
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC535746
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com